Flomoxef

DB11935InvestigationalSmall molecule

Flomoxef has been used in trials studying the treatment of Urinary Tract Infection.

Mechanism: Pharmacologically active on Penicillin-binding protein
Curator reviewed
Formula / weight: C₁₅H₁₈F₂N₆O₇S₂ · 496.46 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyUHRBTBZOWWGKMK-DOMZBBRYSA-NSMILESCO[C@]1(NC(=O)CSC(F)F)[C@H]2OCC(CSC3=NN=NN3CCO)=C(N2C1=O)C(O)=O

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

801Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 12 drug categories

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Flomoxef, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.